title: Managed care considerations. Optimal pharmacotherapy of schizophrenia.
authors.forename: Roger
authors.initials: R
authors.lastname: Muller
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000191:economics / Q000627:therapeutic use; D003692:Delayed-Action Preparations / Q000191:economics; D017048:Health Care Costs; D006801:Humans; D007267:Injections / Q000191:economics; D007348:Insurance, Health / Q000191:economics*; D008329:Managed Care Programs / Q000191:economics*; D015995:Prevalence; D012559:Schizophrenia / Q000188:drug therapy* / Q000191:economics / Q000453:epidemiology; D055502:Secondary Prevention; D014481:United States / Q000453:epidemiology; D016903:Drug Monitoring
chemical_list: D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations